<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent studies have indicated that nodular lymphocyte predominance <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (nLP-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) is a B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Although molecular events in the <z:e sem="disease" ids="C0007621" disease_type="Neoplastic Process" abbrv="">neoplastic transformation</z:e> of B-cells are not well understood, <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">Epstein-Barr virus infection</z:e> and bcl-2 protein overexpression have been postulated to have etiologic roles in some <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Epstein-Barr virus has been demonstrated in the Reed-Sternberg cells of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> cases (other than nLP-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>) as well as in some B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>; bcl-2 overexpression is found in the majority of follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The biologic role for bcl-2 in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> is controversial </plain></SENT>
<SENT sid="4" pm="."><plain>Some reports have indicated the presence of bcl-2 gene rearrangements, associated with the t(14;18) (q32;q21), detected by the polymerase chain reaction in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>; recent studies have failed to confirm this finding </plain></SENT>
<SENT sid="5" pm="."><plain>Reports in the literature describe only a few such analyses in the nLP-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> subtype </plain></SENT>
<SENT sid="6" pm="."><plain>To address these conflicting issues, we examined 12 cases of nLP-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> to determine whether bcl-2 protein expression (by immunohistochemistry) and Epstein-Barr virus (by in situ hybridization) could be detected in the Reed-Sternberg variants </plain></SENT>
<SENT sid="7" pm="."><plain>None of the cases showed expression of bcl-2 protein or Epstein-Barr virus <z:chebi fb="40" ids="33697">RNA</z:chebi> in the neoplastic cells </plain></SENT>
<SENT sid="8" pm="."><plain>Epstein-Barr virus does not appear to play an important role in the pathogenesis of nLP-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Similarly, we cannot substantiate a role for bcl-2 in the development of this type of <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> </plain></SENT>
</text></document>